UK markets closed

MGC Pharmaceuticals Limited (MXC.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
3.7600-0.0600 (-1.57%)
At close: 4:35PM BST
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2020
30/06/2019
30/06/2018
30/06/2017
Total revenue
1,044
2,079
656.237
296.811
120.242
Cost of revenue
782.588
1,905
356.642
119.34
158.073
Gross profit
260.982
174.665
299.595
177.471
-37.831
Operating expenses
Research development
1,608
-
2,866
951.323
-
Selling general and administrative
5,687
4,308
3,423
3,973
4,472
Total operating expenses
10,568
11,979
9,339
7,438
7,282
Operating income or loss
-10,307
-11,805
-9,039
-7,261
-7,320
Interest expense
385.164
135.582
8
99.369
19.724
Total other income/expenses net
-2,207
-6,842
6,969
-1,822
-1,290
Income before tax
-12,883
-18,770
-1,876
-8,990
-8,502
Income tax expense
0
0
27.315
-1.038
0
Income from continuing operations
-12,883
-18,770
-1,904
-8,989
-8,502
Net income
-13,755
-19,363
-2,309
-8,246
-8,144
Net income available to common shareholders
-13,755
-19,363
-2,309
-8,246
-8,144
Basic EPS
-
-0.01
-0.00
-0.01
-0.01
Diluted EPS
-
-0.01
-0.00
-0.01
-0.01
Basic average shares
-
1,382,195
1,209,142
1,125,543
966,344
Diluted average shares
-
1,382,195
1,209,142
1,125,543
966,344
EBITDA
-
-18,153
-1,609
-8,563
-8,399